Naz Rahman
Stock Analyst at Maxim Group
(0.63)
# 2,978
Out of 4,413 analysts
31
Total ratings
22.73%
Success rate
-22.83%
Average return
Main Sectors:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Reiterates: Buy | $23 | $7.58 | +197.03% | 6 | May 1, 2024 | |
| ALIM Alimera Sciences | Initiates: Buy | $10 | $3.67 | +172.48% | 1 | Mar 25, 2024 | |
| AGRX Agile Therapeutics | Downgrades: Hold | n/a | $0.40 | - | 3 | Mar 18, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $120 | $76.72 | +56.41% | 3 | Mar 15, 2024 | |
| QNRX Quoin Pharmaceuticals | Maintains: Buy | $15 → $4 | $0.71 | +463.38% | 2 | Mar 15, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Hold | n/a | $400.03 | - | 1 | Jan 31, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $0.98 | - | 3 | Dec 19, 2023 | |
| PTPI Petros Pharmaceuticals | Initiates: Buy | $4 | $0.65 | +510.78% | 1 | Dec 8, 2023 | |
| PCSA Processa Pharmaceuticals | Downgrades: Hold | n/a | $2.18 | - | 3 | Nov 17, 2023 | |
| AYTU Aytu BioPharma | Initiates: Buy | $5 | $2.92 | +71.23% | 1 | Aug 9, 2023 | |
| SCPH scPharmaceuticals | Maintains: Buy | $13 → $20 | $4.55 | +339.56% | 2 | May 11, 2023 | |
| VRPX Virpax Pharmaceuticals | Initiates: Buy | $40 | $2.78 | +1,338.85% | 1 | Jun 9, 2022 | |
| ATNF 180 Life Sciences | Downgrades: Hold | n/a | $2.10 | - | 1 | May 9, 2022 | |
| NXGL NEXGEL | Initiates: Buy | $6 | $2.12 | +183.02% | 1 | Feb 25, 2022 | |
| NRSN NeuroSense Therapeutics | Initiates: Buy | $7 | $1.34 | +423.56% | 1 | Jan 7, 2022 | |
| FWBI First Wave BioPharma | Downgrades: Hold | n/a | $2.75 | - | 1 | Dec 7, 2021 |
Palisade Bio
May 1, 2024
Reiterates: Buy
Price Target: $23
Current: $7.58
Upside: +197.03%
Alimera Sciences
Mar 25, 2024
Initiates: Buy
Price Target: $10
Current: $3.67
Upside: +172.48%
Agile Therapeutics
Mar 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.40
Upside: -
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $120
Current: $76.72
Upside: +56.41%
Quoin Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $15 → $4
Current: $0.71
Upside: +463.38%
Vertex Pharmaceuticals
Jan 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $400.03
Upside: -
Cingulate
Dec 19, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.98
Upside: -
Petros Pharmaceuticals
Dec 8, 2023
Initiates: Buy
Price Target: $4
Current: $0.65
Upside: +510.78%
Processa Pharmaceuticals
Nov 17, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.18
Upside: -
Aytu BioPharma
Aug 9, 2023
Initiates: Buy
Price Target: $5
Current: $2.92
Upside: +71.23%
scPharmaceuticals
May 11, 2023
Maintains: Buy
Price Target: $13 → $20
Current: $4.55
Upside: +339.56%
Virpax Pharmaceuticals
Jun 9, 2022
Initiates: Buy
Price Target: $40
Current: $2.78
Upside: +1,338.85%
180 Life Sciences
May 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.10
Upside: -
NEXGEL
Feb 25, 2022
Initiates: Buy
Price Target: $6
Current: $2.12
Upside: +183.02%
NeuroSense Therapeutics
Jan 7, 2022
Initiates: Buy
Price Target: $7
Current: $1.34
Upside: +423.56%
First Wave BioPharma
Dec 7, 2021
Downgrades: Hold
Price Target: n/a
Current: $2.75
Upside: -